Moderna Some Approvals Ahead: Is the Stock a Buy?
Moderna’s growth story now centers on a broader mRNA pipeline and FDA decisions. This guide breaks down the upcoming ...
Assessing safety means examining volatility, drawdown risk, and income prospects of index funds versus bonds to determine the calmer route for retirement.
23,779 articlesModerna’s growth story now centers on a broader mRNA pipeline and FDA decisions. This guide breaks down the upcoming ...
As the MiCA deadline approaches, smaller European crypto platforms face a choice between building a regulated stack o...
Oracle just posted its strongest quarter ever with massive cloud backlog, yet investors face a capital-heavy path ahe...
Geopolitical tensions with Iran have rattled energy markets, sending LNG-focused stocks lower while underscoring long...
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
A leading cybersecurity stock surged about 62% in 2026, propelled by artificial intelligence (ai) innovations. This a...
Bitcoin led a broad sell-off, triggering over $600m liquidated hour across major contracts. ETH and XRP followed, as ...
A high-stakes cash bid from Merck KGaA sent Bio-Techne stock higher and sparked a flurry of trading. Here’s what inve...
A tech sector retreat has pulled many chip names lower, but weakness can create entry points. Here are three beaten-d...
World Cup bets on Polymarket surged to $3.3 billion in trading volume, eclipsing the Super Bowl and drawing attention...
When a Lincoln Educational director sold a sizable block of shares, investors took note. This article breaks down the...
If you want steady income from a single stock, think about an integrated energy company that currently yields about 4...